| Literature DB >> 35403607 |
Yujuan Zhang1,2, Kai Lu1,2, Xu Wu3, Hanting Liu1,2, Junyi Xin1,2, Xiaowei Wang1,2, Weida Gong4, Qinghong Zhao5, Meilin Wang1,2,6, Haiyan Chu1,2, Mulong Du1,7, Guoquan Tao3, Zhengdong Zhang1,2,6.
Abstract
The Hedgehog signaling pathway participates in the occurrence and progression of cancers including gastric cancer. We conducted this study to evaluate whether genetic variants in the Hedgehog signaling pathway genes would affect gastric cancer risk. Multi-marker Analysis of GenoMic Annotation (MAGMA) was used to investigate the aggregated genetic effects of single nucleotide polymorphisms (SNPs) assigned to candidate genes. The relationship between SNPs and gastric cancer risk was estimated by multivariate logistic regression analyses. Gene expression was calculated using databases obtained from The Cancer Genome Atlas (TCGA) and The Gene Expression Omnibus (GEO). Kaplan-Meier plotter was used to evaluate the association between gene expression with gastric cancer survival. Tumor Immune Estimation Resource 2.0 (TIMER 2.0) was applied to determine the correlation between selected gene expression and the immune cell infiltration degree. We identified that the G allele of rs2990912 in KIF27 was associated with higher gastric cancer risk, especially in the young and male subgroups. The expression of KIF27 in gastric cancer tissues was higher than that in normal tissues, leading to poor survival in gastric cancer patients. Besides, KIF27 expression was related to immune cell infiltration and positively correlated with PD-L1 expression. Our findings highlight the key role of genetic variation in the Hedgehog signaling pathway genes in gastric cancer susceptibility, which may provide important insights into the diagnosis, prognosis, and treatment of gastric cancer.Entities:
Keywords: Hedgehog signaling pathway; gastric cancer; genetic susceptibility; molecular epidemiology
Year: 2021 PMID: 35403607 PMCID: PMC8894289 DOI: 10.7555/JBR.35.20210091
Source DB: PubMed Journal: J Biomed Res ISSN: 1674-8301
Association between two significant SNPs in the Hedgehog signaling pathway and gastric cancer risk
| Chr | SNP | Gene | Allelea | MAF (case) | MAF (control) | OR (95% CI)b |
|
|
| aReference allele/effect allele; b | ||||||||
| 9 | rs2990912 | A/G | 0.09 | 0.07 | 1.29(1.08–1.54) | 5.53×10–3 | 2.77×10–2 | |
| 9 | rs2065516 | C/T | 0.44 | 0.47 | 0.90(0.82–0.99) | 2.84×10–2 | 7.10×10–2 | |
Association between rs2990912 in KIF27 and gastric cancer risk
| Genotypes | Cases | Controls | OR (95% CI)a |
| |||
| % | % | ||||||
| aORs and | |||||||
| AA | 1324 | 83.4 | 1761 | 86.6 | 1.00 | ||
| AG | 253 | 16.0 | 266 | 13.1 | 1.27 (1.06–1.54) | 1.16×10–2 | |
| GG | 9 | 0.6 | 6 | 0.3 | 1.95 (0.69–5.51) | 2.10×10–1 | |
| Additive model | 1.29 (1.08–1.54) | 5.53×10–3 | |||||
| Dominant model (AG+GG | 1.29 (1.07–1.55) | 7.39×10–3 | |||||
| Recessive model (GG | 1.88 (0.66–5.32) | 2.35×10–1 | |||||
Stratified analysis for rs2990912 and gastric cancer risk in additive model
| Variables | rs2990912 (cases/controls) | OR (95% CI)a |
| |||||||
| AA | AG | GG | ||||||||
| % | % | % | ||||||||
|
aORs and | ||||||||||
| Age (years) | ||||||||||
| <60 | 591/840 | 83.0/87.1 | 115/123 | 16.2/12.8 | 6/1 | 0.8/0.1 | 1.43 (1.10–1.86) | 7.56×10–3 | ||
| ≥60 | 733/921 | 83.9/86.1 | 138/143 | 15.8/13.4 | 3/5 | 0.3/0.5 | 1.17 (0.92–1.49) | 1.94×10–1 | ||
| Sex | ||||||||||
| Male | 1029/1197 | 83.8/86.7 | 191/180 | 15.6/13.0 | 8/4 | 0.6/0.3 | 1.27 (1.03–1.56) | 7.39×10–3 | ||
| Female | 295/564 | 82.4/86.5 | 62/86 | 17.3/13.2 | 1/2 | 0.3/0.3 | 1.34 (0.95–1.89) | 9.32×10–2 | ||